Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Davita Healthcare Partners Inc (DVA)

Davita Healthcare Partners Inc (DVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,431,835
  • Shares Outstanding, K 75,500
  • Annual Sales, $ 12,816 M
  • Annual Income, $ 936,340 K
  • EBIT $ 2,759 M
  • EBITDA $ 3,483 M
  • 60-Month Beta 1.11
  • Price/Sales 0.82
  • Price/Cash Flow 7.27
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 28.39% ( -0.15%)
  • Historical Volatility 19.86%
  • IV Percentile 12%
  • IV Rank 16.22%
  • IV High 57.57% on 04/08/25
  • IV Low 22.74% on 02/18/25
  • Put/Call Vol Ratio 1.79
  • Today's Volume 117
  • Volume Avg (30-Day) 1,046
  • Put/Call OI Ratio 1.14
  • Today's Open Interest 33,326
  • Open Int (30-Day) 33,370

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 2.70
  • Number of Estimates 3
  • High Estimate 2.88
  • Low Estimate 2.47
  • Prior Year 2.59
  • Growth Rate Est. (year over year) +4.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
132.57 +3.61%
on 06/03/25
147.68 -6.99%
on 05/20/25
-7.08 (-4.90%)
since 05/12/25
3-Month
132.57 +3.61%
on 06/03/25
157.12 -12.58%
on 04/11/25
-5.28 (-3.70%)
since 03/12/25
52-Week
131.76 +4.24%
on 08/07/24
179.60 -23.52%
on 01/31/25
-5.34 (-3.74%)
since 06/12/24

Most Recent Stories

More News
Buffett Bought More of This High-Yield Dividend Stock in Q1. Should You Buy It, Too?

BRK.A : 735,000.00 (+0.39%)
BRK.B : 490.34 (+0.45%)
BRK.TO : 36.55 (+0.49%)
ORCL : 199.86 (+13.31%)
SIRI : 21.91 (-3.01%)
DVA : 137.35 (-0.59%)
Made in the USA: Warren Buffett Sells Out of 1 International Stock and Doubles His Stake in 2 U.S. Companies

C : 78.23 (-0.19%)
BAC : 44.62 (-0.25%)
BRK.A : 735,000.00 (+0.39%)
NU : 12.00 (-5.96%)
BRK.B : 490.34 (+0.45%)
BRK-A : N/A (N/A)
BRK.TO : 36.55 (+0.49%)
BYDDY : 104.0000 (-4.38%)
SIRI : 21.91 (-3.01%)
HEI : 304.12 (+0.64%)
DVA : 137.35 (-0.59%)
DPZ : 451.00 (+0.92%)
Buffett's Latest Portfolio Moves, and Another Secret Stock

Buffett's latest 13F shows no new positions in publicly traded companies, but includes a confidential mystery stake, sparking significant speculation.

C : 78.23 (-0.19%)
BAC : 44.62 (-0.25%)
NU : 12.00 (-5.96%)
SIRI : 21.91 (-3.01%)
HEI : 304.12 (+0.64%)
DVA : 137.35 (-0.59%)
TMUS : 228.70 (-0.97%)
OXY : 44.76 (-0.18%)
BRK-B : N/A (N/A)
STZ : 169.81 (+0.46%)
POOL : 295.83 (-1.38%)
COF : 197.68 (-1.42%)
Warren Buffett Just Sold These 8 Stocks, One of Which Remains a Phenomenal Bargain (and a Top Holding of Mine)

The Oracle of Omaha has been a big-time seller of stocks for 10 consecutive quarters -- but there's one sale he may regret.

C : 78.23 (-0.19%)
BAC : 44.62 (-0.25%)
BRK.A : 735,000.00 (+0.39%)
NU : 12.00 (-5.96%)
BRK.B : 490.34 (+0.45%)
BRK-A : N/A (N/A)
BRK.TO : 36.55 (+0.49%)
ORCL : 199.86 (+13.31%)
DVA : 137.35 (-0.59%)
TMUS : 228.70 (-0.97%)
FWONK : 97.43 (+0.42%)
BRK-B : N/A (N/A)
DaVita Stock Outlook: Is Wall Street Bullish or Bearish?

DaVita has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.

XHS : 97.51 (-0.08%)
BCS : 17.76 (+1.20%)
$SPX : 6,045.26 (+0.38%)
DVA : 137.35 (-0.59%)
3 Healthcare Stocks in Hot Water

3 Healthcare Stocks in Hot Water

WST : 224.91 (+0.40%)
DVA : 137.35 (-0.59%)
BMY : 50.69 (+1.06%)
DaVita’s Q1 2025 Earnings: What to Expect

DaVita is expected to unveil its first-quarter results in the upcoming month, and analysts expect a significant double-digit drop in earnings.

XLV : 136.81 (+0.78%)
$SPX : 6,045.26 (+0.38%)
DVA : 137.35 (-0.59%)
3 No-Brainer Warren Buffett Stocks to Buy Right Now

Here are three of Berkshire Hathaway's favorite stocks.

BRK.A : 735,000.00 (+0.39%)
KR : 65.06 (+0.68%)
BRK.B : 490.34 (+0.45%)
BRK-A : N/A (N/A)
BRK-B : N/A (N/A)
AXP : 297.99 (-0.37%)
DVA : 137.35 (-0.59%)
Why DaVita Stock Got Rocked This Week

We're in an age when the threat of cyberattacks is real and substantial. Confirming this, veteran healthcare company DaVita (NYSE: DVA) suffered a hacker ambush in recent days, a situation that spooked...

NFLX : 1,215.03 (-0.40%)
NVDA : 145.00 (+1.52%)
DVA : 137.35 (-0.59%)
Stocks Set for Muted Open as Investors Await U.S. Economic Data and More Big Bank Earnings, Fed Speak on Tap

June S&P 500 E-Mini futures (ESM25) are up +0.05%, and June Nasdaq 100 E-Mini futures (NQM25) are up +0.14% this morning, pointing to a muted open on Wall Street, while investors await U.S. economic data,...

NFLX : 1,215.03 (-0.40%)
UAL : 77.43 (-1.53%)
AAPL : 199.20 (+0.21%)
IBKR : 204.98 (+0.23%)
C : 78.23 (-0.19%)
BAC : 44.62 (-0.25%)
F : 10.53 (-1.22%)
GM : 49.26 (-1.22%)
JNJ : 156.66 (+0.90%)
DVA : 137.35 (-0.59%)
ALGM : 29.89 (-0.50%)
ESM25 : 5,951.50 (-1.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals...

See More

Key Turning Points

3rd Resistance Point 140.93
2nd Resistance Point 139.61
1st Resistance Point 138.48
Last Price 137.35
1st Support Level 136.03
2nd Support Level 134.71
3rd Support Level 133.58

See More

52-Week High 179.60
Fibonacci 61.8% 161.33
Fibonacci 50% 155.68
Fibonacci 38.2% 150.03
Last Price 137.35
52-Week Low 131.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar